-

MEDISCA Names Reflex Medical as Exclusive Partner for SAMIX Mixer Repair and Provides Unique Offer to Clients

PLATTSBURGH, N.Y.--(BUSINESS WIRE)--As the sole distributor of SAMIX mixing machines to the compounding market in the United States and Canada, MEDISCA, a global leader in the personalized pharmaceutical industry, announced an exclusive partnership with Reflex Medical for all repair and servicing of SAMIX machines or otherwise known as electronic mortar and pestle mixers.

Designed for use by compounding pharmacists, the SAMIX mixer utilizes evaporation and contamination-free mixing jars that serve as a convenient and hygienic method for dispensing personalized medications. MEDISCA spent the last three years developing a partnership with SAMIX to ensure their clients across North America have access to this essential and reliable tool, and as of this week, Reflex Medical, a leading medical device manufacturer, will serve as the exclusive repair service provider for these mixers.

Reflex Medical, a Minnesota-based company founded in 2002, specializes in medical device manufacturing and design. As experts on the SAMIX machines, Reflex Medial developed the UnoDose™ Metered-Dose Topical Applicator, a versatile mixing container that doubles as a dispenser and allows the SAMIX to become a one-stop mixing solution for pharmacists.

“This three-way partnership between MEDISCA, SAMIX, and Reflex Medical enables us to provide the best possible equipment and service to our clients in North America,” said Panagiota Danopoulos, Senior Vice President at MEDISCA. “We are constantly striving to streamline and improve our clients’ operations, and we are confident that this agreement will provide the turnkey solutions our customers have come to expect from MEDISCA and its partners.”

MEDISCA also announced a special offer in connection to the partnership agreement, and as of August 1st, MEDISCA is allowing customers who have previously purchased electronic mortar and pestle machines that cannot be repaired to trade them in for a new SAMIX mixer at a reduced price. This offer can be claimed by contacting a MEDISCA sales representative.

MEDISCA is a global supplier to the compounding pharmacy market with over 30 years of experience in the industry, offering the high quality active ingredients, bases, equipment, and devices.

Contacts

Panagiota Danopoulos
661 Route 3, Unit C
Plattsburgh, NY 12901
Medisca.com
1-800-932-1039

More News From MEDISCA

Medisca Enters Its Next Chapter Under Founder Antonio Dos Santos

MONTREAL--(BUSINESS WIRE)--For more than 35 years, Dos Santos has helped shape Medisca into a global leader in pharmaceutical compounding. As Chief Executive Officer, he will lead the company's long-term strategy, with a focus on expanding Medisca's global reach, investing in new areas of growth, strengthening strategic partnerships, and continuing to advance the products, services, education, and expertise that healthcare professionals rely on every day. "When I founded Medisca, my vision was...

Medisca and dsm–firmenich Partner to Expand Access to Pharmaceutical-Grade Vitamin APIs for U.S. Compounding Market

MONTREAL--(BUSINESS WIRE)--Medisca, a global leader in personalized pharmaceutical medicine, has entered into a strategic partnership with dsm–firmenich, a leading ingredient manufacturer serving regulated pharmaceutical markets worldwide. Through this partnership, Medisca will make a portfolio of pharmaceutical-grade vitamin active pharmaceutical ingredients (APIs) available to U.S. compounding professionals, expanding access to ingredients manufactured within European cGMP environments and su...

Medisca Secures Settlement With FlackTek, Reinforcing Patent Strength of MAZ® Mixer

PLATTSBURGH, N.Y.--(BUSINESS WIRE)--Medisca and FlackTek have reached a settlement to resolve their patent dispute relating to the Medisca MAZ® mixer and related mixing technologies set forth in Medisca U.S. patent numbers 10,420,705, 10,765,600, 11,090,224, 11,096,864, 10,231,903, and 10,993,876. The confidential settlement resolves the pending litigation. “This settlement validates the investment Medisca has made over the past decade in the MAZ innovation and technology,” said Sanjay Goorachu...
Back to Newsroom